Sponsor pipeline

Taisho Pharmaceutical Co., Ltd. clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Phase 1		1
Phase 3		4

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT07548853	A Clinical Study of TS-172 in Hyperphosphatemia Patients on Peritoneal Dialysis	Hyperphosphatemia Patients on Peritoneal Dialysis	Recruiting	2026-06-10
NCT07285291	A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis With Phosphate…	Hyperphosphatemia Patients on Hemodialysis	Recruiting	2026-04-17
NCT07285304	A Long-term Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis	Hyperphosphatemia Patients on Hemodialysis	Recruiting	2025-12-16
NCT07548840	A Clinical Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis	Hyperphosphatemia Patients on Hemodialysis	Active, Not Recruiting	2026-10-06
Phase 1
NCT07231029	A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment	Patients With Mild or Moderate Hepatic Impairment	Recruiting	2026-01-09

Get alerts when Taisho Pharmaceutical Co., Ltd.'s trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.